Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept randomized, double-blind, placebo-controlled trial of SC12267 in rheumatoid arthritis
2006-003142-42Phase 2Completed
- Sponsor
- 4SC AG
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vidofludimus calcium in rheumatoid arthritis (RA) (3 arms), sponsored by 4SC AG. Primary endpoint: Primary efficacy endpoint. Started Feb 2007; status: completed.
02
Drugs
vidofludimus calcium
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-003142-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003142-42.